Lexston Mining Corporation Announces Marketing Consulting Services Agreement with Spark Newswire Inc.

Lexston Mining Corporation Announces Marketing Consulting Services Agreement with Spark Newswire Inc.

(TheNewswire)

Vancouver, British Columbia, October 30, 2025 TheNewswire - Lexston Mining Corporation (the "Company" or "Lexston" ) (CSE: LEXT) (OTCQB: LEXTF) (Frankfurt: W5G) announces the Marketing Consulting Services Agreement with Spark Newswire Inc. ( "Spark Newswire" or "Spark" ) (registered address: 800- 885 West Georgia Street, Vancouver, BC V6C3H1, contact person: Steve Hnatko, CMO, email: steve@sparknewswire.com phone: 604-999-7361).  The budget for the services is $100,000 CAD. No compensation in securities of the Company will be paid to Spark Newswire. Spark Newswire is an arm's length party to the Company. To the knowledge of the Company, Spark Newswire does not own securities of the Company .

About Spark Newswire

Spark Newswire is very selective in the clients it works with, only partnering with organizations that have a well-deserved reputation for quality and credibility and only working with one organization within a particular market sector at a time. Spark's goal is to integrate with its clients' values and core brand narratives, becoming an extension of the overall corporate and capital markets team, assisting in building shareholder equity, brand equity and overall market awareness.

Spark Newswire , which operates out of Vancouver, B.C., provides consulting and capital market advisory services to public companies. Through Spark's engagement, the Company hopes to increase investor engagement and create more awareness about the Company.

"Lexston has demonstrated a clear commitment to responsible exploration and strategic growth, which aligns perfectly with Spark's mandate to support high-integrity issuers with strong fundamentals. With Lexston entering a pivotal phase, we're excited to help share their story across the capital markets and unlock broader investor engagement," said Steve Hnatko, chief marketing officer at Spark Newswire.

The Company decided not to proceed with the previously announced Digital Marketing Agreement with Danayi Capital Corp.

About Lexston Mining Corporation

The Company is a Canadian mineral exploration company, focused on the acquisition and development of mineral projects, with the objective to enhance value to all its stakeholders.  The Company has a mineral exploration project in British Columbia, Canada.

The Company (OTCQB: LEXTF) trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. Investors can find Real-Time quotes and market information for the company on www.otcmarkets.com .

On Behalf of the Board of Directors

LEXSTON MINING CORPORATION

Jagdip Bal

Chief Executive Officer

Telephone: (604) 928-8913

Email: jbal@lexston.ca

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Forward-Looking Statements

This news release contains certain "forward-looking statements" relating to anticipated benefits of the agreement with Spark Newswire.  Forward-looking statements are often, but not always, identified by words such as "believe," "anticipate," "estimate," "expect," "intend," "may," "plan," "project," "will," "would," and similar expressions. These statements reflect management's current expectations and assumptions regarding future events and are based on information available to management at the time such statements are made.

Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks include, but are not limited to, general economic and market conditions, competition, regulatory developments, the availability of capital and financing, risks associated with exploration of mineral properties, and other factors disclosed in Lexston's public filings with Canadian securities regulators.

Readers are cautioned not to place undue reliance on forward-looking statements. Although management believes the expectations reflected in such statements are reasonable, actual results may differ materially. Except as required by applicable securities laws, Lexston undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Copyright (c) 2025 TheNewswire - All rights reserved.

News Provided by TheNewsWire via QuoteMedia

LEXT:CNX
The Conversation (0)
Quantum Biopharma

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Reward to be Paid if Information Contributes Significant Evidence Leading to a Trial Victory or Settlement in Landmark USD $700 Million+ Lawsuit

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol... Keep Reading...
Imagion Biosystems

Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its proprietary MagSense® imaging technology, is pleased to provide shareholders with a progress update regarding the Company’s business and... Keep Reading...
Stethoscope on stacked gold coins, symbolizing healthcare costs or medical finance.

Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

President Donald Trump’s new round of tariffs —this time targeting copper— has intensified concerns about rising costs across key sectors, including healthcare. But despite significant price pressures on steel, aluminum, and now copper, all vital to medical device production, there is no... Keep Reading...
Actinogen

Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline

Actinogen Medical ASX: ACW (“ACW” or “the Company”) is pleased to announce that the 100th participant in its pivotal XanaMIA phase 2b/3 randomized trial of Xanamem® for Alzheimer’s disease (AD) has now passed all screening tests and is scheduled for randomization and treatment in July. This... Keep Reading...
Emyria Limited

Medibank to Fund Emyria’s PTSD Program at Perth Clinic

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) a leader in developing and delivering innovative mental health treatments, is pleased to announce that Medibank Private Limited (“Medibank”), Australia’s largest private health insurer, has commenced funding for eligible customers to access... Keep Reading...
ASX:HIQ

HITIQ Announces Exclusive Global Agreement with Shock Doctor for PROTEQT Instrumented Mouthguard

Common Shareholder Questions – Entitlement Offer

HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a pioneer in concussion management, proudly announces an exclusive global agreement with Shock Doctor, the world’s leading mouthguard innovator. This landmark agreement marks Shock Doctor’s two-year effort to design a mouthguard that will... Keep Reading...

Latest Press Releases

Related News